التفاصيل البيبلوغرافية
العنوان: |
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome |
المؤلفون: |
Francesca Palandri, Massimo Breccia, Camilla Mazzoni, Giuseppe Auteri, Elena Maria Elli, Malgorzata M. Trawinska, Nicola Polverelli, Mario Tiribelli, Giulia Benevolo, Alessandra Iurlo, Alessia Tieghi, Florian H. Heidel, Giovanni Caocci, Eloise Beggiato, Gianni Binotto, Francesco Cavazzini, Maurizio Miglino, Costanza Bosi, Monica Crugnola, Monica Bocchia, Bruno Martino, Novella Pugliese, Mattia Biondo, Marta Venturi, Luigi Scaffidi, Alessandro Isidori, Daniele Cattaneo, Mauro Krampera, Fabrizio Pane, Daniela Cilloni, Gianpietro Semenzato, Roberto M. Lemoli, Antonio Cuneo, Elisabetta Abruzzese, Daniela Bartoletti, Simona Paglia, Nicola Vianelli, Michele Cavo, Massimiliano Bonifacio, Giuseppe A. Palumbo |
المصدر: |
Cancer. 129:1704-1713 |
بيانات النشر: |
Wiley, 2023. |
سنة النشر: |
2023 |
مصطلحات موضوعية: |
Cancer Research, Oncology, ruxolitinib, cytopenia, myelofibrosis, myelodepletive phenotype, myeloproliferative neoplasms |
تدمد: |
1097-0142 0008-543X |
الوصول الحر: |
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75234af541a1ffd87d4f63defcaf092aTest https://doi.org/10.1002/cncr.34722Test |
حقوق: |
OPEN |
رقم الانضمام: |
edsair.doi.dedup.....75234af541a1ffd87d4f63defcaf092a |
قاعدة البيانات: |
OpenAIRE |